Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "UC gene" does not refer to a single specific target molecule or receptor but is a common abbreviation used in biomedical literature to describe genes associated with Ulcerative Colitis (UC), a chronic inflammatory bowel disease. These genes typically include those involved in immune regulation, epithelial barrier function, and inflammatory signaling, such as TNF, JAK1, IL23R, and NOD2. In other contexts, "UC gene" may refer to genes of the Urea Cycle (e.g., CPS1, OTC, ASS1) which are frequently dysregulated in various cancers and are being explored as metabolic vulnerabilities for targeted therapy. Because the term is a category rather than a specific entity, therapeutic strategies targeting "UC genes" involve a wide range of mechanisms, from cytokine inhibition to metabolic reprogramming. Biotech analysts should identify the specific gene or pathway intended, as "UC gene" is often used to describe a disease-specific gene signature or a set of susceptibility loci identified through genome-wide association studies.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ulcerative colitis associated gene (UC gene).